By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Innovating, developing, acquiring, and commercializing novel products that target unmet medical need5K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States3M100.00%